Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Science 10 February 1995:
Vol. 267. no. 5199, pp. 886 - 891
DOI: 10.1126/science.7531365
Prev | Table of Contents | Next

Articles

Science, Vol 267, Issue 5199, 886-891
Copyright © 1995 by American Association for the Advancement of Science

articles

Biotherapy of B-cell precursor leukemia by targeting genistein to CD19-associated tyrosine kinases

FM Uckun, WE Evans, CJ Forsyth, KG Waddick, LT Ahlgren, LM Chelstrom, A Burkhardt, J Bolen, and DE Myers

Department of Therapeutic Radiology-Radiation Oncology, University of Minnesota, Minneapolis 55455.

B-cell precursor (BCP) leukemia is the most common form of childhood cancer and the second most common form of acute leukemia in adults. Human BCP leukemia was treated in a severe combined immunodeficient mouse model by targeting of the tyrosine kinase inhibitor Genistein (Gen) to the B cell-specific receptor CD19 with the monoclonal antibody B43. The B43-Gen immunoconjugate bound with high affinity to BCP leukemia cells, selectively inhibited CD19-associated tyrosine kinases, and triggered rapid apoptotic cell death. At less than one-tenth the maximum tolerated dose more than 99.999 percent of human BCP leukemia cells were killed, which led to 100 percent long-term event-free survival from an otherwise invariably fatal leukemia. The B43-Gen immuno-conjugate might be useful in eliminating leukemia cells in patients who have failed conventional therapy.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Isoflavones in breastfed infants after mothers consume soy..
A. A Franke, B. M Halm, L. J Custer, Y. Tatsumura, and S. Hebshi (2006)
Am. J. Clinical Nutrition 84, 406-413
   Abstract »    Full Text »    PDF »
Phase I trial of phenoxodiol delivered by continuous intravenous infusion in patients with solid cancer.
T. K. Choueiri, T. Mekhail, T. E. Hutson, R. Ganapathi, G. E. Kelly, and R. M. Bukowski (2006)
Ann. Onc. 17, 860-865
   Abstract »    Full Text »    PDF »
Isoflavone Genistein: Photoprotection and Clinical Implications in Dermatology.
H. Wei, R. Saladi, Y. Lu, Y. Wang, S. R. Palep, J. Moore, R. Phelps, E. Shyong, and M. G. Lebwohl (2003)
J. Nutr. 133, 3811S-3819
   Abstract »    Full Text »    PDF »
CD19 Function in Early and Late B Cell Development: I. Maintenance of Follicular and Marginal Zone B Cells Requires CD19-Dependent Survival Signals.
D. C. Otero, A. N. Anzelon, and R. C. Rickert (2003)
J. Immunol. 170, 73-83
   Abstract »    Full Text »    PDF »
In Vivo Pharmacokinetic Features, Toxicity Profile, and Chemosensitizing Activity of {alpha}-Cyano-{beta}-hydroxy-{beta}- methyl-N-(2,5-dibromophenyl)propenamide (LFM-A13), a Novel Antileukemic Agent Targeting Bruton's Tyrosine Kinase.
F. M. Uckun, Y. Zheng, M. Cetkovic-Cvrlje, A. Vassilev, E. Lisowski, B. Waurzyniak, H. Chen, R. Carpenter, and C.-L. Chen (2002)
Clin. Cancer Res. 8, 1224-1233
   Abstract »    Full Text »    PDF »
Role of STAT6 in IgE Receptor/Fc{varepsilon}RI-Mediated Late Phase Allergic Responses of Mast Cells.
R. Malaviya and F. M. Uckun (2002)
J. Immunol. 168, 421-426
   Abstract »    Full Text »    PDF »
Bis(4,7-dimethyl-1,10-phenanthroline) Sulfatooxovanadium(IV) as a Novel Antileukemic Agent with Matrix Metalloproteinase Inhibitory Activity.
R. K. Narla, Y. Dong, D. Klis, and F. M. Uckun (2001)
Clin. Cancer Res. 7, 1094-1101
   Abstract »    Full Text »
The Effects of Plant Flavonoids on Mammalian Cells:Implications for Inflammation, Heart Disease, and Cancer.
E. Middleton Jr., C. Kandaswami, and T. C. Theoharides (2000)
Pharmacol. Rev. 52, 673-751
   Abstract »    Full Text »    PDF »
Calpain Inhibitor II Induces Caspase-dependent Apoptosis in Human Acute Lymphoblastic Leukemia and Non-Hodgkin's Lymphoma Cells as Well as Some Solid Tumor Cells.
D.-M. Zhu and F. M. Uckun (2000)
Clin. Cancer Res. 6, 2456-2463
   Abstract »    Full Text »
Bis(4,7-dimethyl-1,10-phenanthroline) Sulfatooxovanadium(IV) as a Novel Apoptosis-inducing Anticancer Agent.
R. K. Narla, Y. Dong, O. J. D’Cruz, C. Navara, and F. M. Uckun (2000)
Clin. Cancer Res. 6, 1546-1556
   Abstract »    Full Text »
Treatment of Therapy-Refractory B-Lineage Acute Lymphoblastic Leukemia with an Apoptosis-inducing CD19-directed Tyrosine Kinase Inhibitor.
F. M. Uckun, Y. Messinger, C.-L. Chen, K. O'Neill, D. E. Myers, F. Goldman, C. Hurvitz, J. T. Casper, and A. Levine (1999)
Clin. Cancer Res. 5, 3906-3913
   Abstract »    Full Text »    PDF »
Specificity of {{alpha}}-Cyano-{{beta}}-Hydroxy-{{beta}}-Methyl-N-[4-(Trifluoromethoxy)Phenyl]-Propenamide as an Inhibitor of the Epidermal Growth Factor Receptor Tyrosine Kinase.
S. Ghosh, Y. Zheng, X. Jun, S. Mahajan, C. Mao, E. A. Sudbeck, and F. M. Uckun (1999)
Clin. Cancer Res. 5, 4264-4272
   Abstract »    Full Text »    PDF »
In Vivo Toxicity and Pharmacokinetic Features of the Janus Kinase 3 Inhibitor WHI-P131 [4-(4'Hydroxyphenyl)-Amino-6,7-Dimethoxyquinazoline].
F. M. Uckun, O. Ek, X.-P. Liu, and C.-L. Chen (1999)
Clin. Cancer Res. 5, 2954-2962
   Abstract »    Full Text »    PDF »
Targeting Janus Kinase 3 in Mast Cells Prevents Immediate Hypersensitivity Reactions and Anaphylaxis.
R. Malaviya, D. Zhu, I. Dibirdik, and F. M. Uckun (1999)
J. Biol. Chem. 274, 27028-27038
   Abstract »    Full Text »    PDF »
Structure-based Design of Specific Inhibitors of Janus Kinase 3 as Apoptosis-inducing Antileukemic Agents.
E. A. Sudbeck, X.-P. Liu, R. K. Narla, S. Mahajan, S. Ghosh, C. Mao, and F. M. Uckun (1999)
Clin. Cancer Res. 5, 1569-1582
   Abstract »    Full Text »    PDF »
ALK+ Lymphoma: Clinico-Pathological Findings and Outcome.
B. Falini, S. Pileri, P. L. Zinzani, A. Carbone, V. Zagonel, C. Wolf-Peeters, G. Verhoef, F. Menestrina, G. Todeschini, M. Paulli, et al. (1999)
Blood 93, 2697-2706
   Abstract »    Full Text »    PDF »
Rational Design and Synthesis of a Novel Anti-leukemic Agent Targeting Bruton's Tyrosine Kinase (BTK), LFM-A13 [alpha -Cyano-beta -Hydroxy-beta -Methyl-N-(2,5-Dibromophenyl)Propenamide].
S. Mahajan, S. Ghosh, E. A. Sudbeck, Y. Zheng, S. Downs, M. Hupke, and F. M. Uckun (1999)
J. Biol. Chem. 274, 9587-9599
   Abstract »    Full Text »    PDF »
Treatment Outcome and Prognostic Factors for Infants With Acute Lymphoblastic Leukemia Treated on Two Consecutive Trials of the Children's Cancer Group.
G. H. Reaman, R. Sposto, M. G. Sensel, B. J. Lange, J. H. Feusner, N. A. Heerema, M. Leonard, E. J. Holmes, H. N. Sather, T. W. Pendergrass, et al. (1999)
J. Clin. Oncol. 17, 445
   Abstract »    Full Text »    PDF »
Bruton's Tyrosine Kinase as an Inhibitor of the Fas/CD95 Death-inducing Signaling Complex.
A. Vassilev, Z. Ozer, C. Navara, S. Mahajan, and F. M. Uckun (1999)
J. Biol. Chem. 274, 1646-1656
   Abstract »    Full Text »    PDF »
Urinary Excretion of Isoflavonoids and the Risk of Breast Cancer.
W. Zheng, Q. Dai, L. J. Custer, X.-O. Shu, W.-Q. Wen, F. Jin, and A. A. Franke (1999)
Cancer Epidemiol. Biomarkers Prev. 8, 35-40
   Abstract »    Full Text »
Pharmacology of CFTR Chloride Channel Activity.
B. D. SCHULTZ, A. K. SINGH, D. C. DEVOR, and R. J. BRIDGES (1999)
Physiol Rev 79, 109-144
   Abstract »    Full Text »    PDF »
Src-Related Protein Tyrosine Kinases in Hematopoiesis.
S. J. Corey and S. M. Anderson (1999)
Blood 93, 1-14
   Full Text »    PDF »
Role of Tyrosine Kinases in Induction of the c-jun Proto-oncogene in Irradiated B-lineage Lymphoid Cells.
P. A. Goodman, L. B. Niehoff, and F. M. Uckun (1998)
J. Biol. Chem. 273, 17742-17748
   Abstract »    Full Text »    PDF »
Antiviral Protection and Germinal Center Formation, But Impaired B Cell Memory in the Absence of CD19.
T. Fehr, R. C. Rickert, B. Odermatt, J. Roes, K. Rajewsky, H. Hengartner, and R. M. Zinkernagel (1998)
J. Exp. Med. 188, 145-155
   Abstract »    Full Text »    PDF »
Stimulation of Src Family Protein-tyrosine Kinases as a Proximal and Mandatory Step for SYK Kinase-dependent Phospholipase Cgamma 2 Activation in Lymphoma B Cells Exposed to Low Energy Electromagnetic Fields.
I. Dibirdik, D. Kristupaitis, T. Kurosaki, L. Tuel-Ahlgren, A. Chu, D. Pond, D. Tuong, R. Luben, and F. M. Uckun (1998)
J. Biol. Chem. 273, 4035-4039
   Abstract »    Full Text »    PDF »
Salidiuretic Action by Genistein in the Isolated, Perfused Rat Kidney.
I. Gimenez, R. M. Martinez, M. Lou, J. A. Mayoral, R. P. Garay, and J. O. Alda (1998)
Hypertension 31, 706-711
   Abstract »    Full Text »    PDF »
Cellular Expression of Antiapoptotic BCL-2 Oncoprotein in Newly Diagnosed Childhood Acute Lymphoblastic Leukemia: A Children's Cancer Group Study.
F. M. Uckun, Z. Yang, H. Sather, P. Steinherz, J. Nachman, B. Bostrom, L. Crotty, M. Sarquis, O. Ek, T. Zeren, et al. (1997)
Blood 89, 3769-3777
   Abstract »    Full Text »    PDF »
A Superantigen-Antibody Fusion Protein for T-Cell Immunotherapy of Human B-Lineage Malignancies.
C. Gidlof, M. Dohlsten, P. Lando, T. Kalland, C. Sundstrom, and T. H. Totterman (1997)
Blood 89, 2089-2097
   Abstract »    Full Text »    PDF »
Signal Transduction through the beta1 Integrin Family Surface Adhesion Molecules VLA-4 and VLA-5 of Human B-cell Precursors Activates CD19 Receptor-associated Protein-tyrosine Kinases.
J. Xiao, Y. Messinger, J. Jin, D. E. Myers, J. B. Bolen, and F. M. Uckun (1996)
J. Biol. Chem. 271, 7659-7664
   Abstract »    Full Text »    PDF »
Physical and Functional Interactions between Lyn and p34[IMAGE] Kinases in Irradiated Human B-cell Precursors.
F. M. Uckun, L. Tuel-Ahlgren, K. G. Waddick, X. Jun, J. Jin, D. E. Myers, R. B. Rowley, A. L. Burkhardt, and J. B. Bolen (1996)
J. Biol. Chem. 271, 6389-6397
   Abstract »    Full Text »    PDF »
Exposure of B-lineage Lymphoid Cells to Low Energy Electromagnetic Fields Stimulates Lyn Kinase.
F. M. Uckun, T. Kurosaki, J. Jin, X. Jun, A. Morgan, M. Takata, J. Bolen, and R. Luben (1995)
J. Biol. Chem. 270, 27666-27670
   Abstract »    Full Text »    PDF »
Thrombin Stimulates Phosphorylation of Insulin-like Growth Factor-1 Receptor, Insulin Receptor Substrate-1, and Phospholipase C-[IMAGE]1 in Rat Aortic Smooth Muscle Cells.
G. N. Rao, P. Delafontaine, and M. S. Runge (1995)
J. Biol. Chem. 270, 27871-27875
   Abstract »    Full Text »    PDF »
Childhood Leukemias.
C.-H. Pui (1995)
N. Engl. J. Med. 332, 1618-1630
   Full Text »    PDF »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)